Laurie E Sower

Laurie has over 15 years experience in directing laboratory operations, quality data system management, and prior experience with TP508. Her prior research at the University of Texas Medical Branch demonstrated a unique TP508 (Chrysalin) receptor-mediated signaling cascade involved in tissue repair. Laurie has been the Principle Investigator (PI/PD) on several of the company’s SBIR grants and contracts and directs all Non-Clinical Regulated Studies for Chrysalis BioTherapeutics.